SlideShare ist ein Scribd-Unternehmen logo
1 von 18
Setting the Stage: Conducting Effective & Strategic Due Diligence Thomas Argentieri, Ph.D. ACI Conference Nov. 17, 2009 New York, NY
Introduction ,[object Object],[object Object],[object Object],[object Object],[object Object]
Introduction ,[object Object],[object Object],[object Object]
Pre-Deal Due Diligence ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],When satisfied with answers to above questions –  Decision to go to full due diligence
…  the objective …  of due diligence
Confirmatory Due Diligence ,[object Object],[object Object],[object Object],[object Object],[object Object]
The Decision to Undertake Due Diligence ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Due Diligence Team Direct costs for 1 day diligence can easily  exceed $40,000-$50,000 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Partial Diligence
Due Diligence Team ,[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Due Diligence Team ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Typical DD Team Makeup (clinical asset) Preclinical Clinical Manufacturing
Team responsibilities: ,[object Object],[object Object],[object Object],[object Object],Due Diligence Team
Examples of Information Requested ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Examples of Information Requested
Product Under Development ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Critical Questions
Critical Questions Marketed Product ,[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Potential Problems
Other Sources of Information ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Conclusions ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],√ √ √ √

Weitere ähnliche Inhalte

Was ist angesagt?

How Oracle Argus Safety 8.x Supports Product Safety Needs
How Oracle Argus Safety 8.x Supports Product Safety NeedsHow Oracle Argus Safety 8.x Supports Product Safety Needs
How Oracle Argus Safety 8.x Supports Product Safety NeedsPerficient, Inc.
 
Strategic Analysis - Sanofi Aventis
Strategic Analysis - Sanofi AventisStrategic Analysis - Sanofi Aventis
Strategic Analysis - Sanofi AventisBruno Rakotozafy
 
Outsourcing in Clinical Research
Outsourcing in Clinical ResearchOutsourcing in Clinical Research
Outsourcing in Clinical ResearchMansi Gaikwad
 
Pharma marketing
Pharma marketingPharma marketing
Pharma marketingUzair Ahmed
 
Ann Rockley — Managing the Complexities of the Core Data Sheet (CDS)
Ann Rockley — Managing the Complexities of the Core Data Sheet (CDS)Ann Rockley — Managing the Complexities of the Core Data Sheet (CDS)
Ann Rockley — Managing the Complexities of the Core Data Sheet (CDS)Ann Rockley
 
Market Sizing PowerPoint Presentation Slides
Market Sizing PowerPoint Presentation SlidesMarket Sizing PowerPoint Presentation Slides
Market Sizing PowerPoint Presentation SlidesSlideTeam
 
Operating Model and Organization Design Toolkit
Operating Model and Organization Design Toolkit Operating Model and Organization Design Toolkit
Operating Model and Organization Design Toolkit Aurelien Domont, MBA
 
Pharmacovigilance and product quality assessment
Pharmacovigilance and product quality assessmentPharmacovigilance and product quality assessment
Pharmacovigilance and product quality assessmentpi
 
business development.pdf
business development.pdfbusiness development.pdf
business development.pdfNOMRCYREBEL
 
Deconstructing all types of monitoring visits
Deconstructing  all types of monitoring visitsDeconstructing  all types of monitoring visits
Deconstructing all types of monitoring visitsDan Sfera
 
Introduction to clinical research - II
Introduction to clinical research - IIIntroduction to clinical research - II
Introduction to clinical research - IIPradeep H
 
Understanding Pre-sales & Sales Cycle
Understanding Pre-sales & Sales CycleUnderstanding Pre-sales & Sales Cycle
Understanding Pre-sales & Sales CyclePranshu Joshi
 
Clinical trial supply management
Clinical trial supply managementClinical trial supply management
Clinical trial supply managementDipesh Pabrekar
 
Audit in Pharmacovigilance
Audit in PharmacovigilanceAudit in Pharmacovigilance
Audit in Pharmacovigilanceclarityeye
 
Setting up an R&D Organisation
Setting up an R&D OrganisationSetting up an R&D Organisation
Setting up an R&D OrganisationJoe Drumgoole
 
The Basics of Business Development
The Basics of Business DevelopmentThe Basics of Business Development
The Basics of Business DevelopmentMoatasem Mabrouk
 

Was ist angesagt? (20)

How Oracle Argus Safety 8.x Supports Product Safety Needs
How Oracle Argus Safety 8.x Supports Product Safety NeedsHow Oracle Argus Safety 8.x Supports Product Safety Needs
How Oracle Argus Safety 8.x Supports Product Safety Needs
 
Strategic Analysis - Sanofi Aventis
Strategic Analysis - Sanofi AventisStrategic Analysis - Sanofi Aventis
Strategic Analysis - Sanofi Aventis
 
Outsourcing in Clinical Research
Outsourcing in Clinical ResearchOutsourcing in Clinical Research
Outsourcing in Clinical Research
 
Pharma marketing
Pharma marketingPharma marketing
Pharma marketing
 
Ann Rockley — Managing the Complexities of the Core Data Sheet (CDS)
Ann Rockley — Managing the Complexities of the Core Data Sheet (CDS)Ann Rockley — Managing the Complexities of the Core Data Sheet (CDS)
Ann Rockley — Managing the Complexities of the Core Data Sheet (CDS)
 
Market Sizing PowerPoint Presentation Slides
Market Sizing PowerPoint Presentation SlidesMarket Sizing PowerPoint Presentation Slides
Market Sizing PowerPoint Presentation Slides
 
Operating Model and Organization Design Toolkit
Operating Model and Organization Design Toolkit Operating Model and Organization Design Toolkit
Operating Model and Organization Design Toolkit
 
Pharmacovigilance and product quality assessment
Pharmacovigilance and product quality assessmentPharmacovigilance and product quality assessment
Pharmacovigilance and product quality assessment
 
Turacoz - Clinical Study Report
Turacoz - Clinical Study ReportTuracoz - Clinical Study Report
Turacoz - Clinical Study Report
 
business development.pdf
business development.pdfbusiness development.pdf
business development.pdf
 
Deconstructing all types of monitoring visits
Deconstructing  all types of monitoring visitsDeconstructing  all types of monitoring visits
Deconstructing all types of monitoring visits
 
FDA Inspection
FDA InspectionFDA Inspection
FDA Inspection
 
Pharmacovigilance AND HIPAA
Pharmacovigilance AND HIPAA Pharmacovigilance AND HIPAA
Pharmacovigilance AND HIPAA
 
Introduction to clinical research - II
Introduction to clinical research - IIIntroduction to clinical research - II
Introduction to clinical research - II
 
Cro perspectives
Cro perspectivesCro perspectives
Cro perspectives
 
Understanding Pre-sales & Sales Cycle
Understanding Pre-sales & Sales CycleUnderstanding Pre-sales & Sales Cycle
Understanding Pre-sales & Sales Cycle
 
Clinical trial supply management
Clinical trial supply managementClinical trial supply management
Clinical trial supply management
 
Audit in Pharmacovigilance
Audit in PharmacovigilanceAudit in Pharmacovigilance
Audit in Pharmacovigilance
 
Setting up an R&D Organisation
Setting up an R&D OrganisationSetting up an R&D Organisation
Setting up an R&D Organisation
 
The Basics of Business Development
The Basics of Business DevelopmentThe Basics of Business Development
The Basics of Business Development
 

Andere mochten auch

M&A Law: The Lawyer's Role; Recent Delaware Developments
M&A Law: The Lawyer's Role; Recent Delaware DevelopmentsM&A Law: The Lawyer's Role; Recent Delaware Developments
M&A Law: The Lawyer's Role; Recent Delaware DevelopmentsStephen Bainbridge
 
Sample due diligence checklist
Sample due diligence checklistSample due diligence checklist
Sample due diligence checklistLuis Espinosa
 
Successful Legal Due Diligence Strategies
Successful Legal Due Diligence StrategiesSuccessful Legal Due Diligence Strategies
Successful Legal Due Diligence StrategiesLawPlus Ltd.
 
Due Diligence - What You Don’t Find Out Will Hurt You
Due Diligence - What You Don’t Find Out Will Hurt YouDue Diligence - What You Don’t Find Out Will Hurt You
Due Diligence - What You Don’t Find Out Will Hurt YouNow Dentons
 
Browne Jacobson - Education Law Conference 2016 - Workshop stream 1, Efficien...
Browne Jacobson - Education Law Conference 2016 - Workshop stream 1, Efficien...Browne Jacobson - Education Law Conference 2016 - Workshop stream 1, Efficien...
Browne Jacobson - Education Law Conference 2016 - Workshop stream 1, Efficien...Browne Jacobson LLP
 
EY activities and solutions for insurers focusing on the emerging consumers
EY activities and solutions for insurers focusing on the emerging consumersEY activities and solutions for insurers focusing on the emerging consumers
EY activities and solutions for insurers focusing on the emerging consumersEY
 
Ey top-10-risks-in-telecommunications-2014
Ey top-10-risks-in-telecommunications-2014Ey top-10-risks-in-telecommunications-2014
Ey top-10-risks-in-telecommunications-2014CMR WORLD TECH
 
Business Plans & Due Diligence
Business Plans & Due DiligenceBusiness Plans & Due Diligence
Business Plans & Due DiligenceEurofast
 
The Six Highest Performing B2B Blog Post Formats
The Six Highest Performing B2B Blog Post FormatsThe Six Highest Performing B2B Blog Post Formats
The Six Highest Performing B2B Blog Post FormatsBarry Feldman
 
1633946 - EY Services brochure 2015 FV
1633946 - EY Services brochure 2015 FV1633946 - EY Services brochure 2015 FV
1633946 - EY Services brochure 2015 FVFran Viau
 
EY Valuation & Business Modelling - Luxembourg office
EY Valuation & Business Modelling - Luxembourg officeEY Valuation & Business Modelling - Luxembourg office
EY Valuation & Business Modelling - Luxembourg officeeyluxembourg
 
Due Diligence for Merger & Acquisition, Corporate Restructuring and Takeover
Due Diligence for Merger & Acquisition, Corporate Restructuring and TakeoverDue Diligence for Merger & Acquisition, Corporate Restructuring and Takeover
Due Diligence for Merger & Acquisition, Corporate Restructuring and TakeoverPavan Kumar Vijay
 
Due Diligence Best Practices and Pitfalls
Due Diligence Best Practices and PitfallsDue Diligence Best Practices and Pitfalls
Due Diligence Best Practices and PitfallsFirmex
 
EY Analyse Gewinnwarnungen 2011-2016.pptx
EY Analyse Gewinnwarnungen 2011-2016.pptxEY Analyse Gewinnwarnungen 2011-2016.pptx
EY Analyse Gewinnwarnungen 2011-2016.pptxEY
 
Dealing in a digital world - strategies to future-proof your business
Dealing in a digital world - strategies to future-proof your businessDealing in a digital world - strategies to future-proof your business
Dealing in a digital world - strategies to future-proof your businessEY
 
Blockchain in capital markets and structured finance
Blockchain in capital markets and structured financeBlockchain in capital markets and structured finance
Blockchain in capital markets and structured financeEY
 
The impact of innovation on the future of IVD
The impact of innovation on the future of IVDThe impact of innovation on the future of IVD
The impact of innovation on the future of IVDEY
 
EMLI Training-Legal Due Diligence for Acquisition Deal in Indonesian Mining P...
EMLI Training-Legal Due Diligence for Acquisition Deal in Indonesian Mining P...EMLI Training-Legal Due Diligence for Acquisition Deal in Indonesian Mining P...
EMLI Training-Legal Due Diligence for Acquisition Deal in Indonesian Mining P...EMLI Indonesia
 

Andere mochten auch (20)

M&A Law: The Lawyer's Role; Recent Delaware Developments
M&A Law: The Lawyer's Role; Recent Delaware DevelopmentsM&A Law: The Lawyer's Role; Recent Delaware Developments
M&A Law: The Lawyer's Role; Recent Delaware Developments
 
Sample due diligence checklist
Sample due diligence checklistSample due diligence checklist
Sample due diligence checklist
 
Successful Legal Due Diligence Strategies
Successful Legal Due Diligence StrategiesSuccessful Legal Due Diligence Strategies
Successful Legal Due Diligence Strategies
 
Due Diligence - What You Don’t Find Out Will Hurt You
Due Diligence - What You Don’t Find Out Will Hurt YouDue Diligence - What You Don’t Find Out Will Hurt You
Due Diligence - What You Don’t Find Out Will Hurt You
 
Browne Jacobson - Education Law Conference 2016 - Workshop stream 1, Efficien...
Browne Jacobson - Education Law Conference 2016 - Workshop stream 1, Efficien...Browne Jacobson - Education Law Conference 2016 - Workshop stream 1, Efficien...
Browne Jacobson - Education Law Conference 2016 - Workshop stream 1, Efficien...
 
EY activities and solutions for insurers focusing on the emerging consumers
EY activities and solutions for insurers focusing on the emerging consumersEY activities and solutions for insurers focusing on the emerging consumers
EY activities and solutions for insurers focusing on the emerging consumers
 
Project ppt
Project pptProject ppt
Project ppt
 
Ey top-10-risks-in-telecommunications-2014
Ey top-10-risks-in-telecommunications-2014Ey top-10-risks-in-telecommunications-2014
Ey top-10-risks-in-telecommunications-2014
 
Business Plans & Due Diligence
Business Plans & Due DiligenceBusiness Plans & Due Diligence
Business Plans & Due Diligence
 
The Six Highest Performing B2B Blog Post Formats
The Six Highest Performing B2B Blog Post FormatsThe Six Highest Performing B2B Blog Post Formats
The Six Highest Performing B2B Blog Post Formats
 
1633946 - EY Services brochure 2015 FV
1633946 - EY Services brochure 2015 FV1633946 - EY Services brochure 2015 FV
1633946 - EY Services brochure 2015 FV
 
EY Valuation & Business Modelling - Luxembourg office
EY Valuation & Business Modelling - Luxembourg officeEY Valuation & Business Modelling - Luxembourg office
EY Valuation & Business Modelling - Luxembourg office
 
Aldrich aimes
Aldrich aimesAldrich aimes
Aldrich aimes
 
Due Diligence for Merger & Acquisition, Corporate Restructuring and Takeover
Due Diligence for Merger & Acquisition, Corporate Restructuring and TakeoverDue Diligence for Merger & Acquisition, Corporate Restructuring and Takeover
Due Diligence for Merger & Acquisition, Corporate Restructuring and Takeover
 
Due Diligence Best Practices and Pitfalls
Due Diligence Best Practices and PitfallsDue Diligence Best Practices and Pitfalls
Due Diligence Best Practices and Pitfalls
 
EY Analyse Gewinnwarnungen 2011-2016.pptx
EY Analyse Gewinnwarnungen 2011-2016.pptxEY Analyse Gewinnwarnungen 2011-2016.pptx
EY Analyse Gewinnwarnungen 2011-2016.pptx
 
Dealing in a digital world - strategies to future-proof your business
Dealing in a digital world - strategies to future-proof your businessDealing in a digital world - strategies to future-proof your business
Dealing in a digital world - strategies to future-proof your business
 
Blockchain in capital markets and structured finance
Blockchain in capital markets and structured financeBlockchain in capital markets and structured finance
Blockchain in capital markets and structured finance
 
The impact of innovation on the future of IVD
The impact of innovation on the future of IVDThe impact of innovation on the future of IVD
The impact of innovation on the future of IVD
 
EMLI Training-Legal Due Diligence for Acquisition Deal in Indonesian Mining P...
EMLI Training-Legal Due Diligence for Acquisition Deal in Indonesian Mining P...EMLI Training-Legal Due Diligence for Acquisition Deal in Indonesian Mining P...
EMLI Training-Legal Due Diligence for Acquisition Deal in Indonesian Mining P...
 

Ähnlich wie Technical Due Diligence

Strategies for Conducting New Product Scientific Assessment - Yavuz SILAY - D...
Strategies for Conducting New Product Scientific Assessment - Yavuz SILAY - D...Strategies for Conducting New Product Scientific Assessment - Yavuz SILAY - D...
Strategies for Conducting New Product Scientific Assessment - Yavuz SILAY - D...Yavuz Silay
 
Speeding Towards Commercialization Gra 121808 Final
Speeding Towards Commercialization   Gra 121808 FinalSpeeding Towards Commercialization   Gra 121808 Final
Speeding Towards Commercialization Gra 121808 Finalsecurbme
 
How much does it cost to launch and commercialize a companion diagnostic test?
How much does it cost to launch and commercialize a companion diagnostic test?How much does it cost to launch and commercialize a companion diagnostic test?
How much does it cost to launch and commercialize a companion diagnostic test?Diaceutics Group
 
Product Complaints: Complaint Handling from Intake to Closure
Product Complaints: Complaint Handling from Intake to ClosureProduct Complaints: Complaint Handling from Intake to Closure
Product Complaints: Complaint Handling from Intake to ClosureGRCTS
 
Four Practical Approaches To Managing A More Effective Device Trial
Four Practical Approaches To Managing A More Effective Device TrialFour Practical Approaches To Managing A More Effective Device Trial
Four Practical Approaches To Managing A More Effective Device TrialDavid Levin
 
Compliant Dissemination of Promotional and Educational Material
Compliant Dissemination of Promotional and Educational MaterialCompliant Dissemination of Promotional and Educational Material
Compliant Dissemination of Promotional and Educational MaterialGood Promotional Practices
 
Real-Life Compliance Solutions: Part I
Real-Life Compliance Solutions: Part IReal-Life Compliance Solutions: Part I
Real-Life Compliance Solutions: Part IProlifiq Software
 
Regulatory, Quality & Clinical Due Diligence: The Oft Overlooked Keys to Suc...
Regulatory, Quality & Clinical Due Diligence:  The Oft Overlooked Keys to Suc...Regulatory, Quality & Clinical Due Diligence:  The Oft Overlooked Keys to Suc...
Regulatory, Quality & Clinical Due Diligence: The Oft Overlooked Keys to Suc...Michael Swit
 
PACE: A Collaborative Process, Elsa Chi Abruzzo, President, ARAC, LLC
PACE: A Collaborative Process, Elsa Chi Abruzzo, President, ARAC, LLCPACE: A Collaborative Process, Elsa Chi Abruzzo, President, ARAC, LLC
PACE: A Collaborative Process, Elsa Chi Abruzzo, President, ARAC, LLCProlifiq Software
 
2015-11 Mary Syto CTS SoCal Challenges in Global Supply Mgmt in Small Biotech
2015-11 Mary Syto CTS SoCal Challenges in Global Supply Mgmt in Small Biotech2015-11 Mary Syto CTS SoCal Challenges in Global Supply Mgmt in Small Biotech
2015-11 Mary Syto CTS SoCal Challenges in Global Supply Mgmt in Small BiotechMary Syto
 
Drug Regulatory Affairs
Drug Regulatory AffairsDrug Regulatory Affairs
Drug Regulatory AffairsNamdeo Shinde
 
Drug Development Life Cycle - Costs and Revenue
Drug Development Life Cycle - Costs and RevenueDrug Development Life Cycle - Costs and Revenue
Drug Development Life Cycle - Costs and RevenueRobert Sturm
 
Research and Best Practices
Research and Best PracticesResearch and Best Practices
Research and Best PracticesMr.Yes!
 
CASE STUDY ON CORPORATE VENTURE CAPITAL FOR PHARMA INDUSTRY FOR "DELOITTE-MA...
CASE STUDY ON  CORPORATE VENTURE CAPITAL FOR PHARMA INDUSTRY FOR "DELOITTE-MA...CASE STUDY ON  CORPORATE VENTURE CAPITAL FOR PHARMA INDUSTRY FOR "DELOITTE-MA...
CASE STUDY ON CORPORATE VENTURE CAPITAL FOR PHARMA INDUSTRY FOR "DELOITTE-MA...Debi Prasad Dash
 
Highlights from ExL Pharma's 4th Latin America Clinical Trials
Highlights from  ExL Pharma's 4th Latin America Clinical TrialsHighlights from  ExL Pharma's 4th Latin America Clinical Trials
Highlights from ExL Pharma's 4th Latin America Clinical TrialsExL Pharma
 
Pharma Regulatory & licensing Service
Pharma Regulatory & licensing ServicePharma Regulatory & licensing Service
Pharma Regulatory & licensing ServiceVikram sathish Asokan
 

Ähnlich wie Technical Due Diligence (20)

Strategies for Conducting New Product Scientific Assessment - Yavuz SILAY - D...
Strategies for Conducting New Product Scientific Assessment - Yavuz SILAY - D...Strategies for Conducting New Product Scientific Assessment - Yavuz SILAY - D...
Strategies for Conducting New Product Scientific Assessment - Yavuz SILAY - D...
 
SMI Talk
SMI TalkSMI Talk
SMI Talk
 
Speeding Towards Commercialization Gra 121808 Final
Speeding Towards Commercialization   Gra 121808 FinalSpeeding Towards Commercialization   Gra 121808 Final
Speeding Towards Commercialization Gra 121808 Final
 
How much does it cost to launch and commercialize a companion diagnostic test?
How much does it cost to launch and commercialize a companion diagnostic test?How much does it cost to launch and commercialize a companion diagnostic test?
How much does it cost to launch and commercialize a companion diagnostic test?
 
Product Complaints: Complaint Handling from Intake to Closure
Product Complaints: Complaint Handling from Intake to ClosureProduct Complaints: Complaint Handling from Intake to Closure
Product Complaints: Complaint Handling from Intake to Closure
 
Regulatory Affairs
Regulatory AffairsRegulatory Affairs
Regulatory Affairs
 
Four Practical Approaches To Managing A More Effective Device Trial
Four Practical Approaches To Managing A More Effective Device TrialFour Practical Approaches To Managing A More Effective Device Trial
Four Practical Approaches To Managing A More Effective Device Trial
 
Compliant Dissemination of Promotional and Educational Material
Compliant Dissemination of Promotional and Educational MaterialCompliant Dissemination of Promotional and Educational Material
Compliant Dissemination of Promotional and Educational Material
 
Real-Life Compliance Solutions: Part I
Real-Life Compliance Solutions: Part IReal-Life Compliance Solutions: Part I
Real-Life Compliance Solutions: Part I
 
Regulatory, Quality & Clinical Due Diligence: The Oft Overlooked Keys to Suc...
Regulatory, Quality & Clinical Due Diligence:  The Oft Overlooked Keys to Suc...Regulatory, Quality & Clinical Due Diligence:  The Oft Overlooked Keys to Suc...
Regulatory, Quality & Clinical Due Diligence: The Oft Overlooked Keys to Suc...
 
PACE: A Collaborative Process, Elsa Chi Abruzzo, President, ARAC, LLC
PACE: A Collaborative Process, Elsa Chi Abruzzo, President, ARAC, LLCPACE: A Collaborative Process, Elsa Chi Abruzzo, President, ARAC, LLC
PACE: A Collaborative Process, Elsa Chi Abruzzo, President, ARAC, LLC
 
2015-11 Mary Syto CTS SoCal Challenges in Global Supply Mgmt in Small Biotech
2015-11 Mary Syto CTS SoCal Challenges in Global Supply Mgmt in Small Biotech2015-11 Mary Syto CTS SoCal Challenges in Global Supply Mgmt in Small Biotech
2015-11 Mary Syto CTS SoCal Challenges in Global Supply Mgmt in Small Biotech
 
Drug Regulatory Affairs
Drug Regulatory AffairsDrug Regulatory Affairs
Drug Regulatory Affairs
 
Drug Development Life Cycle - Costs and Revenue
Drug Development Life Cycle - Costs and RevenueDrug Development Life Cycle - Costs and Revenue
Drug Development Life Cycle - Costs and Revenue
 
Research and Best Practices
Research and Best PracticesResearch and Best Practices
Research and Best Practices
 
Biotechnology Consulting
Biotechnology ConsultingBiotechnology Consulting
Biotechnology Consulting
 
CASE STUDY ON CORPORATE VENTURE CAPITAL FOR PHARMA INDUSTRY FOR "DELOITTE-MA...
CASE STUDY ON  CORPORATE VENTURE CAPITAL FOR PHARMA INDUSTRY FOR "DELOITTE-MA...CASE STUDY ON  CORPORATE VENTURE CAPITAL FOR PHARMA INDUSTRY FOR "DELOITTE-MA...
CASE STUDY ON CORPORATE VENTURE CAPITAL FOR PHARMA INDUSTRY FOR "DELOITTE-MA...
 
Highlights from ExL Pharma's 4th Latin America Clinical Trials
Highlights from  ExL Pharma's 4th Latin America Clinical TrialsHighlights from  ExL Pharma's 4th Latin America Clinical Trials
Highlights from ExL Pharma's 4th Latin America Clinical Trials
 
Quality and Regulatory Affairs
Quality and Regulatory AffairsQuality and Regulatory Affairs
Quality and Regulatory Affairs
 
Pharma Regulatory & licensing Service
Pharma Regulatory & licensing ServicePharma Regulatory & licensing Service
Pharma Regulatory & licensing Service
 

Technical Due Diligence

  • 1. Setting the Stage: Conducting Effective & Strategic Due Diligence Thomas Argentieri, Ph.D. ACI Conference Nov. 17, 2009 New York, NY
  • 2.
  • 3.
  • 4.
  • 5. … the objective … of due diligence
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.